EMEA-001904-PIP03-18-M02
Key facts
| Active substance |
Brincidofovir
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0180/2022
|
| PIP number |
EMEA-001904-PIP03-18-M02
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of smallpox
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Chimerix IRL Limited
E-mail: contact@chimerix.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|